These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10522271)

  • 41. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of rat faecal metabolites of ebastine by B/E linked scanning liquid secondary ion mass spectrometry.
    Yoshida K; Hatoyama T; Fujii T; Kagemoto A; Miyazaki H; Naruto S
    Biol Mass Spectrom; 1994 Jul; 23(7):385-90. PubMed ID: 7915143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of primary metabolites of ranolazine in dog urine by LC-MS(n)].
    Tang JY; Wang W; Li L; Zhang CG; Wang DM; Sun L
    Yao Xue Xue Bao; 2012 Aug; 47(8):1031-8. PubMed ID: 23162900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of the metabolites of a new hypoglycaemic agent, midaglizole, in dogs.
    Nakaoka M; Hakusui H
    Xenobiotica; 1987 Nov; 17(11):1329-39. PubMed ID: 3433802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.
    Singh R; Chen IW; Jin L; Silva MV; Arison BH; Lin JH; Wong BK
    Drug Metab Dispos; 2001 Dec; 29(12):1578-87. PubMed ID: 11717177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of (R)-(+)-pulegone in F344 rats.
    Chen LJ; Lebetkin EH; Burka LT
    Drug Metab Dispos; 2001 Dec; 29(12):1567-77. PubMed ID: 11717176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.
    Agostini O; Bonacchi G; Coppini G; Toja E; Triolo A; Manzini S; Pieraccini G; Moneti G
    Drug Metab Dispos; 1994; 22(2):259-68. PubMed ID: 7516853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir.
    Anari MR; Sanchez RI; Bakhtiar R; Franklin RB; Baillie TA
    Anal Chem; 2004 Feb; 76(3):823-32. PubMed ID: 14750881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion with hydroxypropylcellulose.
    Yamada T; Saito N; Anraku M; Imai T; Otagiri M
    Pharm Dev Technol; 2000; 5(4):443-54. PubMed ID: 11109244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-depyridination and N-dedimethylaminoethylation of tripelennamine and pyrilamine in the rat. New metabolic pathways.
    Yeh SY
    Drug Metab Dispos; 1990; 18(4):453-61. PubMed ID: 1976067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biotransformation of a 1,5-benzodiazepine, triflubazam, by man.
    Alton KB; Grimes RM; Shaw C; Patrick JE; McGuire JL
    Drug Metab Dispos; 1975; 3(5):352-60. PubMed ID: 241616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of the quantitative metabolic fate and urinary excretion of 3-methyl-4-trifluoromethylaniline and 3-methyl-4-trifluoromethylacetanilide in the rat.
    Scarfe GB; Lindon JC; Nicholson JK; Wright B; Clayton E; Wilson ID
    Drug Metab Dispos; 1999 Oct; 27(10):1171-8. PubMed ID: 10497144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.